Pharmaceuticals, namely, live biotherapeutics for the treatment of irritable bowel syndrome (IBS) and intestinal disorders; live biotherapeutic bacterial formulations for medical use, namely, the treatment of irritable bowel syndrome (IBS) and intestinal disorders; preparations of microorganisms for medical use